BioCentury | Jan 23, 2021
Emerging Company Profile

Technology showcase: BioCentury’s 2020 class of emerging companies

...Sangamo Therapeutics Inc. (NASDAQ:SGMO) and Spark launched Kriya Therapeutics Inc....
BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...goal, it’s focusing simultaneously on R&D and building infrastructure, including in-house manufacturing. Founded in 2019, Kriya Therapeutics Inc....
...and MafA from the University of Pittsburgh in February. Kriya declined to comment. COMPANY PROFILE Kriya Therapeutics Inc....
...musculoaponeurotic fibrosarcoma oncogene homolog A PDX1 (IPF1) - Pancreatic and duodenal homeobox 1 Sandi Wong, Assistant Editor Kriya Therapeutics Inc. gene...
Items per page:
1 - 2 of 2
BioCentury | Jan 23, 2021
Emerging Company Profile

Technology showcase: BioCentury’s 2020 class of emerging companies

...Sangamo Therapeutics Inc. (NASDAQ:SGMO) and Spark launched Kriya Therapeutics Inc....
BioCentury | May 14, 2020
Emerging Company Profile

Kriya emerges with $80.5M A round, three gene therapies for diabetes and obesity

...goal, it’s focusing simultaneously on R&D and building infrastructure, including in-house manufacturing. Founded in 2019, Kriya Therapeutics Inc....
...and MafA from the University of Pittsburgh in February. Kriya declined to comment. COMPANY PROFILE Kriya Therapeutics Inc....
...musculoaponeurotic fibrosarcoma oncogene homolog A PDX1 (IPF1) - Pancreatic and duodenal homeobox 1 Sandi Wong, Assistant Editor Kriya Therapeutics Inc. gene...
Items per page:
1 - 2 of 2